Neuromodulatory treatment of recalcitrant plaque psoriasis with onabotulinumtoxinA - 10/11/18
Funding sources: Supported in part by an investigator-initiated grant from Allergan to Dr Hordinsky and a grant from the University of Minnesota Undergraduate Research Opportunities Program. |
|
Disclosure: At the time of submission, Dr Hordinsky was an investigator for an Allergan, Inc, clinical trial focused on the therapy of male androgenetic alopecia. Dr Aschenbeck, Dr Kennedy, Dr Wendelschafer-Crabb, Dr Ericson, Dr Kavand, Dr Bertin, Dr Dykstra, and Dr Panoutsopoulou have no conflicts of interest to disclose. |
|
Presented in poster and oral presentation at the 75th Annual Meeting of the Society for Investigative Dermatology in Scottsdale, AZ, on May 11-14, 2016. |
|
Reprints not available from the authors. |
Vol 79 - N° 6
P. 1156-1159 - décembre 2018 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?